Literature DB >> 24649874

Impact of consultant-led care in early pregnancy unit.

T L Tan1, C L K Khoo, S Sawant.   

Abstract

Early pregnancy complication remains a significant cause of maternal morbidity and mortality. Despite the paucity of evidence to support consultant-led early pregnancy unit over nurse- or sonographer-led services, hospitals have devoted scarce resources to appoint consultants to lead their early pregnancy units. We compared the management and outcomes of confirmed and suspected ectopic pregnancy 1 year before and one year after the transition from a nurse-led to a consultant-led early pregnancy unit in a London hospital. Our study showed improvements in the rates of negative laparoscopy, ruptured ectopic pregnancy during follow-up, need for laparotomy, ITU admission and length of stay and statistically significant reduction in operative intervention, without concomitant rise in morbidity or mortality in women with confirmed or suspected ectopic pregnancies.

Entities:  

Keywords:  Acute gynaecology; consultant; early pregnancy unit; ectopic pregnancy

Mesh:

Year:  2014        PMID: 24649874     DOI: 10.3109/01443615.2014.896324

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  2 in total

1.  Women's experiences of early pregnancy assessment unit services: a qualitative investigation.

Authors:  J A Hall; S A Silverio; G Barrett; M Memtsa; V Goodhart; R Bender-Atik; J Stephenson; D Jurkovic
Journal:  BJOG       Date:  2021-09-07       Impact factor: 7.331

2.  Differences in the organisation of early pregnancy units and the effect of senior clinician presence, volume of patients and weekend opening on emergency hospital admissions: Findings from the VESPA Study.

Authors:  Maria Memtsa; Venetia Goodhart; Gareth Ambler; Peter Brocklehurst; Edna Keeney; Sergio A Silverio; Zacharias Anastasiou; Jeff Round; Nazim Khan; Jennifer Hall; Geraldine Barrett; Ruth Bender-Atik; Judith Stephenson; Davor Jurkovic
Journal:  PLoS One       Date:  2021-11-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.